Denali Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 13.06 M | $215.59 M | 8.88% | 7.57% |
| BLACKROCK, INC. | 02/12/2026 | 12.72 M | $209.93 M | 3.46% | 7.37% |
| BAILLIE GIFFORD & CO | 01/23/2026 | 12.31 M | $203.25 M | 6.21% | 7.14% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 7.25 M | $119.77 M | 28.65% | 4.21% |
| TEMASEK HOLDINGS (PRIVATE) LTD | 02/17/2026 | 7.01 M | $115.78 M | 30.94% | 4.07% |
| STATE STREET CORP | 02/13/2026 | 6.26 M | $103.41 M | 14.62% | 3.63% |
| FMR LLC | 02/17/2026 | 6.10 M | $100.66 M | -3.83% | 3.54% |
| NORGES BANK | 02/10/2026 | 5.12 M | $84.52 M | 100.00% | 2.97% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 4.98 M | $82.28 M | -8.81% | 2.89% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 3.92 M | $64.65 M | -14.28% | 2.27% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 3.84 M | $63.33 M | 77.28% | 2.22% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 3.73 M | $61.61 M | 0.00% | 2.16% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/11/2026 | 3.73 M | $61.57 M | -21.67% | 2.16% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 3.56 M | $58.74 M | 1.07% | 2.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.46 M | $57.10 M | -0.23% | 2.01% |
| HOLOCENE ADVISORS, LP | 02/17/2026 | 3.15 M | $52.05 M | 0.54% | 1.83% |
| CRESTLINE MANAGEMENT, LP | 02/17/2026 | 2.81 M | $46.41 M | -17.59% | 1.63% |
| FISHER ASSET MANAGEMENT, LLC | 02/09/2026 | 2.59 M | $42.75 M | 58.71% | 1.50% |
| UBS GROUP AG | 01/29/2026 | 2.40 M | $39.70 M | 19.50% | 1.39% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 2.37 M | $39.20 M | 0.73% | 1.38% |
| ABRDN PLC | 01/16/2026 | 2.03 M | $33.56 M | 82.56% | 1.18% |
| CASDIN CAPITAL, LLC | 02/17/2026 | 1.84 M | $30.38 M | 106.74% | 1.07% |
| LYNX1 CAPITAL MANAGEMENT LP | 02/17/2026 | 1.74 M | $28.71 M | 564.44% | 1.01% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.70 M | $28.07 M | -32.53% | 0.99% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 1.52 M | $25.16 M | 19.90% | 0.88% |
| SIREN, L.L.C. | 02/13/2026 | 1.40 M | $23.06 M | 69.99% | 0.81% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.33 M | $21.98 M | 166.27% | 0.77% |
| MORGAN STANLEY | 02/13/2026 | 1.22 M | $20.14 M | -27.80% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.20 M | $19.82 M | 4.26% | 0.70% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.20 M | $19.81 M | -2.79% | 0.70% |
| CANDRIAM S.C.A. | 04/30/2026 | 1.17 M | $19.26 M | 39.92% | 0.68% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 1.02 M | $16.89 M | 100.00% | 0.59% |
| MASTERS CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.00 M | $16.51 M | 33.33% | 0.58% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/17/2026 | 1.00 M | $16.51 M | 0.00% | 0.58% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 932.14 K | $15.39 M | -3.02% | 0.54% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 859.11 K | $14.18 M | 100.00% | 0.50% |
| CITADEL ADVISORS LLC | 02/17/2026 | 779.15 K | $12.86 M | 13.21% | 0.45% |
| MARSHALL WACE, LLP | 02/13/2026 | 763.89 K | $12.61 M | -2.94% | 0.44% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 762.09 K | $12.58 M | -4.83% | 0.44% |
| 02/13/2026 | 656.71 K | $10.84 M | 100.00% | 0.38% | |
| PALO ALTO INVESTORS LP | 02/17/2026 | 641.24 K | $10.59 M | 57.16% | 0.37% |
| CERCANO MANAGEMENT LLC | 02/10/2026 | 625.00 K | $10.32 M | 0.00% | 0.36% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 591.46 K | $9.77 M | -36.83% | 0.34% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 590.31 K | $9.75 M | 158.92% | 0.34% |
| SEGALL BRYANT & HAMILL, LLC | 02/13/2026 | 537.00 K | $8.87 M | 4.69% | 0.31% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 515.72 K | $8.51 M | -3.44% | 0.30% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 465.00 K | $7.68 M | 100.00% | 0.27% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 450.99 K | $7.40 M | 115.17% | 0.26% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 450.00 K | $7.43 M | 47.54% | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 430.18 K | $7.10 M | 61.54% | 0.25% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Denali Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 362 institutional investors and hedge funds held shares of Denali Therapeutics Inc. The most heavily invested institutionals were:
BAILLIE GIFFORD & CO: 12.07 M
Temasek Holdings (Private) Ltd: 7.01 M
DIMENSIONAL FUND ADVISORS LP: 2.69 M
UBS Group AG: 2.57 M
Pictet Asset Management Holding SA: 2.56 M
Fisher Asset Management, LLC: 2.44 M
87.66% of Denali Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 181.21 M shares in the last 24 months. This purchase volume represents approximately $3.86 B in transactions.